Hiroshi Koide
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroshi Koide has a total of 184 co-authors. Here are the top co-authors by number of shared publications:
Takashi Yokota
Department of Stem Cell Biology, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan
13 shared publications- Tadayuki Akagi
Department of Life, Environment, and Applied Chemistry, Faculty of Engineering, Fukuoka Institute of Technology, Fukuoka, Japan
12 shared publications Yoshito Kaziro
Faculty of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama, Japan
11 shared publications- Shigeyuki Yokoyama
RIKEN Cluster for Science, Technology and Innovation Hub, Yokohama, Japan
9 shared publications - Hiroki Ura
Center for Clinical Genomics, Kanazawa Medical University Hospital, Uchinada, Ishikawa, Japan
7 shared publications Chuanhai Sun
Department of Stem Cell Biology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan
5 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 47
Overexpression of regenerating islet-derived type 4 isoform 2 increases colorectal cancer cell proliferation
- 3 July 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 47
Open AccessOverexpression of regenerating islet-derived type 4 isoform 2 increases colorectal cancer cell proliferation
- Open Access
- 1 January 2023
- Published by EHU Press in The International Journal of Developmental Biology
- Vol. 67 (4) , 147-153
The stem cell transcription factor ZFP296 transforms NIH3T3 cells and promotes anchorage-independent growth of cancer cells
Cancer cells and embryonic stem (ES) cells share several biological properties, suggesting that some genes expressed in ES cells may play an important role in cancer cell growth. In this study, we investigated the possible role of zinc finger protein 296 (ZFP296), a transcription factor expressed in ES cells, in cancer development. First, we found that overexpression of Zfp296 in NIH3T3 mouse fibroblasts induced two phenomena indicative of cell transformation: enhanced proliferation under low-serum conditions and anchorage-independent growth. We also found that Zfp296 expression was upregulated in the tumor area of a mouse model of colon carcinogenesis. In addition, the expression levels of ZFP296 in various human cell lines were generally low in normal cells and relatively high in cancer cells. Finally, using a soft agar assay, we found that overexpression of ZFP296 promoted the anchorage-independent growth of cancer cells, while its knockdown had the opposite effect. Overall, these results suggest a possible role of the ES-specific transcription factor ZFP296 in cancer.
- 1 January 2023
- Published by EHU Press in The International Journal of Developmental Biology
- Vol. 67 (4) , 147-153
Open AccessThe stem cell transcription factor ZFP296 transforms NIH3T3 cells and promotes anchorage-independent growth of cancer cells
Cancer cells and embryonic stem (ES) cells share several biological properties, suggesting that some genes expressed in ES cells may play an important role in cancer cell growth. In this study, we investigated the possible role of zinc finger protein 296 (ZFP296), a transcription factor expressed in ES cells, in cancer development. First, we found that overexpression of Zfp296 in NIH3T3 mouse fibroblasts induced two phenomena indicative of cell transformation: enhanced proliferation under low-serum conditions and anchorage-independent growth. We also found that Zfp296 expression was upregulated in the tumor area of a mouse model of colon carcinogenesis. In addition, the expression levels of ZFP296 in various human cell lines were generally low in normal cells and relatively high in cancer cells. Finally, using a soft agar assay, we found that overexpression of ZFP296 promoted the anchorage-independent growth of cancer cells, while its knockdown had the opposite effect. Overall, these results suggest a possible role of the ES-specific transcription factor ZFP296 in cancer.
- 1 May 2019
- Published by Elsevier in Journal of Surgical Research
- Vol. 237, 22-29
The Embryonic Stem Cell-Specific Transcription Factor ZFP57 Promotes Liver Metastasis of Colorectal Cancer
- 1 May 2019
- Published by Elsevier in Journal of Surgical Research
- Vol. 237, 22-29
The Embryonic Stem Cell-Specific Transcription Factor ZFP57 Promotes Liver Metastasis of Colorectal Cancer
- Open Access
- 27 February 2018
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 23 (1) , 8
Platelet-derived growth factor-C functions as a growth factor in mouse embryonic stem cells and human fibrosarcoma cells
- 27 February 2018
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 23 (1) , 8
Open AccessPlatelet-derived growth factor-C functions as a growth factor in mouse embryonic stem cells and human fibrosarcoma cells
- Open Access
- 1 September 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (37) , 22460-22473
ETS-related Transcription Factors ETV4 and ETV5 Are Involved in Proliferation and Induction of Differentiation-associated Genes in Embryonic Stem (ES) Cells
- 1 September 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (37) , 22460-22473
Open AccessETS-related Transcription Factors ETV4 and ETV5 Are Involved in Proliferation and Induction of Differentiation-associated Genes in Embryonic Stem (ES) Cells
- 1 April 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 459 (3) , 374-378
Oct3/4 directly regulates expression of E2F3a in mouse embryonic stem cells
- 1 April 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 459 (3) , 374-378
Oct3/4 directly regulates expression of E2F3a in mouse embryonic stem cells
- Open Access
- 1 October 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 453 (4) , 817-820
Nanog positively regulates Zfp57 expression in mouse embryonic stem cells
- 1 October 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 453 (4) , 817-820
Open AccessNanog positively regulates Zfp57 expression in mouse embryonic stem cells
- Open Access
- 27 January 2014
- Published by Springer Nature in Oncogene
- Vol. 34 (6) , 752-760
The stem cell transcription factor ZFP57 induces IGF2 expression to promote anchorage-independent growth in cancer cells
Several common biological properties between cancer cells and embryonic stem (ES) cells suggest the possibility that some genes expressed in ES cells might have important roles in cancer cell growth. The transcription factor ZFP57 is expressed in self-renewing ES cells and its expression level decreases during ES cell differentiation. This study showed that ZFP57 is involved in the anchorage-independent growth of human fibrosarcoma HT1080 cells in soft agar. ZFP57 overexpression enhanced, whereas knockdown suppressed, HT1080 tumor formation in nude mice. Furthermore, ZFP57 regulates the expression of insulin-like growth factor 2 (IGF2), which has a critical role in ZFP57-induced anchorage-independent growth. ZFP57 also promotes anchorage-independent growth in ES cells and immortal fibroblasts. Finally, immunohistochemical analysis revealed that ZFP57 is overexpressed in human cancer clinical specimens. Taken together, these results suggest that the ES-specific transcription factor ZFP57 is a novel oncogene.
- 27 January 2014
- Published by Springer Nature in Oncogene
- Vol. 34 (6) , 752-760
Open AccessThe stem cell transcription factor ZFP57 induces IGF2 expression to promote anchorage-independent growth in cancer cells
Several common biological properties between cancer cells and embryonic stem (ES) cells suggest the possibility that some genes expressed in ES cells might have important roles in cancer cell growth. The transcription factor ZFP57 is expressed in self-renewing ES cells and its expression level decreases during ES cell differentiation. This study showed that ZFP57 is involved in the anchorage-independent growth of human fibrosarcoma HT1080 cells in soft agar. ZFP57 overexpression enhanced, whereas knockdown suppressed, HT1080 tumor formation in nude mice. Furthermore, ZFP57 regulates the expression of insulin-like growth factor 2 (IGF2), which has a critical role in ZFP57-induced anchorage-independent growth. ZFP57 also promotes anchorage-independent growth in ES cells and immortal fibroblasts. Finally, immunohistochemical analysis revealed that ZFP57 is overexpressed in human cancer clinical specimens. Taken together, these results suggest that the ES-specific transcription factor ZFP57 is a novel oncogene.
- 1 November 2013
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 441 (2) , 411-417
Zfp296 is a novel Klf4-interacting protein and functions as a negative regulator
- 1 November 2013
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 441 (2) , 411-417
Zfp296 is a novel Klf4-interacting protein and functions as a negative regulator
- Open Access
- 1 May 2013
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 33 (10) , 2056-2066
Dax1 Associates with Esrrb and Regulates Its Function in Embryonic Stem Cells
Self-renewal capacity and pluripotency, which are controlled by the Oct3/4-centered transcriptional regulatory network, are major characteristics of embryonic stem (ES) cells. Nuclear hormone receptor Dax1 is one of the crucial factors in the network. Here, we identified an orphan nuclear receptor, Esrrb (estrogen-related receptor beta), as a Dax1-interacting protein. Interaction of Dax1 and Esrrb was mediated through LXXLL motifs of Dax1 and the activation- and ligand-binding domains of Esrrb. Furthermore, Esrrb enhanced the promoter activity of the Dax1 gene via direct binding to Esrrb-binding site 1 (ERRE1, where “ERRE” represents “Esrrb-responsive element”) of the promoter. Expression of Dax1 was suppressed followed by Oct3/4 repression; however, overexpression of Esrrb maintained expression of Dax1 even in the absence of Oct3/4, indicating that Dax1 is a direct downstream target of Esrrb and that Esrrb can regulate Dax1 expression in an Oct3/4-independent manner. We also found that the transcriptional activity of Esrrb was repressed by Dax1. Furthermore, we revealed that Oct3/4, Dax1, and Esrrb have a competitive inhibition capacity for each complex. These data, together with previous findings, suggest that Dax1 functions as a negative regulator of Esrrb and Oct3/4, and these molecules form a regulatory loop for controlling the pluripotency and self-renewal capacity of ES cells.
- 1 May 2013
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 33 (10) , 2056-2066
Open AccessDax1 Associates with Esrrb and Regulates Its Function in Embryonic Stem Cells
Self-renewal capacity and pluripotency, which are controlled by the Oct3/4-centered transcriptional regulatory network, are major characteristics of embryonic stem (ES) cells. Nuclear hormone receptor Dax1 is one of the crucial factors in the network. Here, we identified an orphan nuclear receptor, Esrrb (estrogen-related receptor beta), as a Dax1-interacting protein. Interaction of Dax1 and Esrrb was mediated through LXXLL motifs of Dax1 and the activation- and ligand-binding domains of Esrrb. Furthermore, Esrrb enhanced the promoter activity of the Dax1 gene via direct binding to Esrrb-binding site 1 (ERRE1, where “ERRE” represents “Esrrb-responsive element”) of the promoter. Expression of Dax1 was suppressed followed by Oct3/4 repression; however, overexpression of Esrrb maintained expression of Dax1 even in the absence of Oct3/4, indicating that Dax1 is a direct downstream target of Esrrb and that Esrrb can regulate Dax1 expression in an Oct3/4-independent manner. We also found that the transcriptional activity of Esrrb was repressed by Dax1. Furthermore, we revealed that Oct3/4, Dax1, and Esrrb have a competitive inhibition capacity for each complex. These data, together with previous findings, suggest that Dax1 functions as a negative regulator of Esrrb and Oct3/4, and these molecules form a regulatory loop for controlling the pluripotency and self-renewal capacity of ES cells.